Dongmei Lin

4.0k total citations
107 papers, 1.8k citations indexed

About

Dongmei Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Dongmei Lin has authored 107 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 37 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Dongmei Lin's work include Lung Cancer Treatments and Mutations (25 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Lung Cancer Diagnosis and Treatment (17 papers). Dongmei Lin is often cited by papers focused on Lung Cancer Treatments and Mutations (25 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Lung Cancer Diagnosis and Treatment (17 papers). Dongmei Lin collaborates with scholars based in China, Ethiopia and United States. Dongmei Lin's co-authors include Xin Yang, Xiaozheng Huang, Wenqiang Wei, Xiu‐Qing Li, Lixin Zhou, Jun Hou, Guoqing Wang, Yutong He, Zhiwei Dong and Hao Feng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Dongmei Lin

101 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongmei Lin China 21 666 589 463 312 195 107 1.8k
Youngchul Kim United States 29 676 1.0× 411 0.7× 813 1.8× 370 1.2× 164 0.8× 193 2.5k
Wei Qian China 23 775 1.2× 528 0.9× 465 1.0× 421 1.3× 247 1.3× 98 1.9k
David Chang United States 25 1.4k 2.2× 415 0.7× 1000 2.2× 465 1.5× 125 0.6× 68 2.9k
Hongcheng Zhu China 27 527 0.8× 431 0.7× 929 2.0× 333 1.1× 128 0.7× 97 1.9k
Haibo Wang China 27 677 1.0× 370 0.6× 1.2k 2.7× 262 0.8× 128 0.7× 165 2.5k
Hongyan Wu China 25 475 0.7× 401 0.7× 703 1.5× 237 0.8× 97 0.5× 154 2.1k
Bahram Memar Iran 22 486 0.7× 197 0.3× 520 1.1× 341 1.1× 54 0.3× 87 1.4k
Jiamei Yang China 28 568 0.9× 372 0.6× 629 1.4× 587 1.9× 46 0.2× 108 2.1k
Bo Jiang China 28 832 1.2× 722 1.2× 879 1.9× 775 2.5× 62 0.3× 188 2.9k

Countries citing papers authored by Dongmei Lin

Since Specialization
Citations

This map shows the geographic impact of Dongmei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongmei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongmei Lin more than expected).

Fields of papers citing papers by Dongmei Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongmei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongmei Lin. The network helps show where Dongmei Lin may publish in the future.

Co-authorship network of co-authors of Dongmei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Dongmei Lin. A scholar is included among the top collaborators of Dongmei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongmei Lin. Dongmei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yukun, Yang Yao, Qiaoling Zhang, et al.. (2025). A novel galactoglucan from Ganoderma lucidum ameliorates ethanol-induced gastric ulcers by modulating FAK-MAPK signaling pathway. Carbohydrate Polymers. 360. 123594–123594. 2 indexed citations
2.
3.
4.
Yang, Teng, et al.. (2024). Ganoderma Lucidum polysaccharide peptide (GL-PP2): A potential therapeutic agent against sepsis-induced organ injury by modulating Nrf2/NF-κB pathways. International Journal of Biological Macromolecules. 285. 138378–138378. 2 indexed citations
5.
Lin, Dongmei, et al.. (2024). P3.08F.05 Four-Cycle Compared with Two-Cycle Neoadjuvant Chemoimmunotherapy Achieved a Higher Rate of pCR: Preliminary Results of a Phase III Trial. Journal of Thoracic Oncology. 19(10). S339–S340. 1 indexed citations
6.
Lin, Dongmei, et al.. (2024). Research on lung sound classification model based on dual-channel CNN-LSTM algorithm. Biomedical Signal Processing and Control. 94. 106257–106257. 17 indexed citations
7.
Zhang, Yukun, et al.. (2024). Structural characterization and anti-oxidative activity for a glycopeptide from Ganoderma lucidum fruiting body. International Journal of Biological Macromolecules. 261(Pt 2). 129793–129793. 18 indexed citations
8.
Lin, Dongmei, Yukun Zhang, Hang Zhang, et al.. (2023). Ganoderma lucidum polysaccharide peptides GL-PPSQ2 alleviate intestinal ischemia-reperfusion injury via inhibiting cytotoxic neutrophil extracellular traps. International Journal of Biological Macromolecules. 244. 125370–125370. 26 indexed citations
9.
Meng, Meng, Lianfu Wang, Yang Yao, et al.. (2023). Ganoderma lucidum polysaccharide peptide (GLPP) attenuates rheumatic arthritis in rats through inactivating NF-κB and MAPK signaling pathways. Phytomedicine. 119. 155010–155010. 43 indexed citations
10.
Wang, Yan, Bing Liu, Qingjie Min, et al.. (2023). Spatial transcriptomics delineates molecular features and cellular plasticity in lung adenocarcinoma progression. Cell Discovery. 9(1). 96–96. 34 indexed citations
11.
Qin, Yu, Jing Zhou, Ru Chen, et al.. (2022). Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study. Cancer Medicine. 11(21). 4033–4042. 8 indexed citations
12.
Wang, Yaqi, Xin Yang, Bing Liu, et al.. (2022). Percentage of Newly Proposed High-Grade Patterns Is Associated with Prognosis of Pathological T1-2N0M0 Lung Adenocarcinoma. Annals of Surgical Oncology. 29(7). 4437–4447. 7 indexed citations
13.
Ran, Jianhua, Yuwei Ye, Yongpan An, et al.. (2021). Ganoderic acid improves 5-fluorouracil-induced cognitive dysfunction in mice. Food & Function. 12(24). 12325–12337. 19 indexed citations
14.
Wu, Jianghua, Wei Sun, Xiaodan Yang, et al.. (2021). FP07.03 Landscape Heterogeneity of PD-L1 Expression and Immune Cells Predicts Prognosis of Metastatic Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(3). S203–S204. 1 indexed citations
15.
Lin, Dongmei & Xiaodan Yang. (2019). P2.09-14 Evaluation on Inter-Assay Consistency and Inter-Reader Precision for PD-L1 Assays: Ventana SP263 and Dako 22C3 in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S774–S774. 1 indexed citations
16.
Tian, Dan, Yuquan Pei, Qingfeng Zheng, et al.. (2017). Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non‐small cell lung cancer. Thoracic Cancer. 8(2). 97–105. 18 indexed citations
17.
Bai, Yanhua, Dongfeng Niu, Xiaozheng Huang, et al.. (2017). PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma. Diagnostic Pathology. 12(1). 72–72. 38 indexed citations
18.
Kang, Xiaozheng, Zhen Huang, Anhui Shi, et al.. (2016). [Deficiencies in the Diagnosis and Treatment of Pulmonary Metastatic Osteosarcoma: A Chinese Multidisciplinary Survey].. SHILAP Revista de lepidopterología. 19(3). 153–60. 1 indexed citations
19.
Shi, Yunfei, Zifen Gao, Cuiling Liu, et al.. (2016). [Expression of CD137 in tumor cells of Hodgkin lymphoma from Northern China and its application in pathological differential diagnosis].. PubMed. 37(6). 484–90. 2 indexed citations
20.
Sun, Wei, et al.. (2014). Significance of nonmucinous lepidic component with mild nuclear atypia in the discrimination of multiple primary lung cancers from intrapulmonary metastases.. PubMed Central. 7(11). 7583–96. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youngchul Kim Breakdown of academic impact, for papers by Wei Qian Breakdown of academic impact, for papers by David Chang Breakdown of academic impact, for papers by Hongcheng Zhu Breakdown of academic impact, for papers by Haibo Wang Breakdown of academic impact, for papers by Hongyan Wu Breakdown of academic impact, for papers by Bahram Memar Breakdown of academic impact, for papers by Jiamei Yang Breakdown of academic impact, for papers by Bo Jiang
Rankless by CCL
2026